GUIDING CELLS TO IMPROVE LIFE Trademark

Trademark Overview

On Thursday, July 29, 2010, a trademark application was filed for GUIDING CELLS TO IMPROVE LIFE with the United States Patent and Trademark Office. The USPTO has given the GUIDING CELLS TO IMPROVE LIFE trademark a serial number of 85096313. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 14, 2014. This trademark is owned by Fate Therapeutics, Inc.. The GUIDING CELLS TO IMPROVE LIFE trademark is filed in the Chemical Products category with the following description:

reagents for research, including drug discovery and development; diagnostic reagents for clinical and medical laboratory use
guiding cells to improve life

General Information

Serial Number85096313
Word MarkGUIDING CELLS TO IMPROVE LIFE
Filing DateThursday, July 29, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 14, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2011

Trademark Statements

Goods and Servicesreagents for research, including drug discovery and development; diagnostic reagents for clinical and medical laboratory use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, August 3, 2010
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFate Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameFate Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, April 14, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 14, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, September 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2013EXTENSION 5 GRANTED
Wednesday, September 4, 2013EXTENSION 5 FILED
Wednesday, September 4, 2013TEAS EXTENSION RECEIVED
Friday, March 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 7, 2013EXTENSION 4 GRANTED
Monday, March 4, 2013EXTENSION 4 FILED
Monday, March 4, 2013TEAS EXTENSION RECEIVED
Tuesday, August 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 27, 2012EXTENSION 3 GRANTED
Thursday, August 23, 2012EXTENSION 3 FILED
Thursday, August 23, 2012TEAS EXTENSION RECEIVED
Tuesday, March 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 12, 2012EXTENSION 2 GRANTED
Tuesday, February 14, 2012EXTENSION 2 FILED
Friday, March 9, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 14, 2012TEAS EXTENSION RECEIVED
Saturday, September 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 1, 2011EXTENSION 1 GRANTED
Thursday, September 1, 2011EXTENSION 1 FILED
Thursday, September 1, 2011TEAS EXTENSION RECEIVED
Tuesday, March 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 11, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 8, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 8, 2010ASSIGNED TO LIE
Tuesday, November 16, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 12, 2010ASSIGNED TO EXAMINER
Tuesday, August 3, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 2, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

life improve cells guiding reagents clinical medical laboratory diagnostic discovery research including drug development